Olema Pharmaceuticals, Inc. (OLMA) › Operating IncomeOlema Pharmaceuticals, Inc. (OLMA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$4.32M2020: -$21.53M2021: -$71.49M2022: -$106.99M2023: -$104.96M2024: -$142.26M2025: -$178.70M-$178.70M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$178.70M-25.6%2024-$142.26M-35.5%2023-$104.96M+1.9%2022-$106.99M-49.7%2021-$71.49M-232.1%2020-$21.53M-398.0%2019-$4.32M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share